Today: 27 June 2026
Visa stock price jumps nearly 4% as V rebounds; traders eye jobs-report delays next
3 February 2026
1 min read

Visa stock price jumps nearly 4% as V rebounds; traders eye jobs-report delays next

New York, Feb 2, 2026, 19:36 EST — After-hours.

  • Visa shares were last up 3.8% on Monday, outpacing most payments peers.
  • Investors are still digesting Visa’s holiday-quarter beat and outlook, with cross-border trends back in view.
  • A partial U.S. government shutdown has thrown key labor-market data timing into question.

Visa stock price climbed on Monday, with shares last up 3.8% at $333.84 in late trading, as the payments giant regained ground after a choppy stretch for U.S. financials.

The move matters because Visa’s network sits under a wide slice of consumer and business spending. When the stock moves hard, it tends to tug the broader card-and-payments group with it, especially when investors are jumpy about growth.

It also came as Wall Street ended higher, with the Dow up 1.05% and the S&P 500 rising 0.54% as traders leaned on fresh economic signals and a shift back into risk after a brief selloff.

Visa’s latest catalyst remains last week’s quarterly update, where it beat Wall Street estimates as payment volumes rose through the holiday season. Chief executive Ryan McInerney called the quarter “very strong,” while analysts flagged a cautious tone around expenses and watched cross-border growth — a proxy for travel and trade — for signs of cooling. Visa also highlighted work to integrate stablecoins, crypto tokens designed to track the dollar, including a pilot that lets some U.S. banks settle using USDC issued by Circle. Reuters

The gains were broadly in line with the group. Mastercard was up 3.1% on the day, while American Express was little changed. PayPal slipped 0.6%.

Macro is complicating the read-through. The U.S. Labor Department said the January jobs report will be delayed because of the partial government shutdown, a snag for investors trying to judge whether spending is holding up into early 2026.

There is also policy risk hanging over the group. Donald Trump has called for a cap on credit card interest rates, while Visa and Mastercard have faced pressure around merchant fees, including a revised settlement framework that would lower swipe fees if approved. Separately, the U.S. Department of Justice has sued Visa, alleging it monopolized debit network markets — a case the company has denied.

For Visa bulls, the near-term debate is familiar: can cross-border growth re-accelerate without a fresh hit from tariffs, and can the company absorb higher operating expenses (the day-to-day costs of running the business) without giving up margin.

Next up, traders are watching for clarity on the labor-data calendar. The U.S. Bureau of Labor Statistics schedule still lists the Employment Situation report for January on Friday, Feb. 6 at 08:30 a.m. Eastern time, while warning release dates are subject to change due to the lapse in government services.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Telix Pharmaceuticals and Two Australian Insider-Led Growth Stocks Highlighted
    June 27, 2026, 11:07 AM EDT. Telix Pharmaceuticals (ASX:TLX), a A$5.2 billion biopharmaceutical firm specializing in radiopharmaceuticals for cancer imaging and treatment, draws growth-focused investors despite ongoing losses. The company reported US$621.9 million revenue from Precision Medicine and relies heavily on its oncology pipeline with products like Illuccix and late-stage candidates TLX591 and TLX101. Key risks include high R&D costs, regulatory scrutiny, pricing pressures, and trial dependencies. Also featured are two Australian insider-led growth stocks identified by the Fast Growing Stocks With High Insider Ownership screener, highlighting firms with aligned management-shareholder interests amid mixed inflation and cautious central bank policies.

Latest articles

GameStop (NYSE:GME) holds close to cash levels after company guides for $600 million in EBITDA

GameStop (NYSE:GME) holds close to cash levels after company guides for $600 million in EBITDA

27 June 2026
GameStop surged 3.57% to $21.76 and jumped after hours as it forecast FY2026 adjusted EBITDA above $600 million, nearly doubling from 2025; with a $9.76 billion market cap now close to its $9.7 billion in cash, securities, digital assets, and collateral, investors are weighing whether GameStop’s cash-rich balance sheet can support equity while Ryan Cohen pursues an eBay bid.
ImmunityBio (NASDAQ:IBRX) trades after post-Russell spike with 46% more volume

ImmunityBio (NASDAQ:IBRX) trades after post-Russell spike with 46% more volume

27 June 2026
ImmunityBio surged 11.8% to $8.71 on Friday with volume tripling its average, as Russell index reconstitution took effect; Monday’s trading will reveal if demand persists or if the spike was driven by index flows, with no imminent company events and recent insider selling accounting for just 0.06% of Friday’s volume.
Lucid (NASDAQ:LCID) jumps, adding about $312 million after $158 million cost plan

Lucid (NASDAQ:LCID) jumps, adding about $312 million after $158 million cost plan

27 June 2026
Lucid surged 15.6% Friday, adding $312 million in equity value—almost double the $158 million in annualized savings from this week’s restructuring plan that cut 18% of its U.S. workforce. Friday’s volume equaled 54% of reported short interest, but the rally outpaced cost-cutting fundamentals, leaving less room for further gains based solely on headcount cuts.
Court ruling on student loans hits private lenders’ health grad loan push

Court ruling on student loans hits private lenders’ health grad loan push

27 June 2026
Judge blocks narrow “professional degree” rule, letting more health-care grad students keep higher federal loan caps; $7.87B in 2023-24 borrowing above new limits remains in federal market, trimming but not eliminating the $4.5B-$5B annual private loan growth Sallie Mae projected from Grad PLUS loan cuts.
Johnson & Johnson stock rises as new Erleada survival data lands
Previous Story

Johnson & Johnson stock rises as new Erleada survival data lands

Amphenol stock price steadies near $145 after earnings whipsaw as traders eye Tuesday’s U.S. shutdown vote
Next Story

Amphenol stock price steadies near $145 after earnings whipsaw as traders eye Tuesday’s U.S. shutdown vote

Go toTop